Key facts
- This page summarizes Adam H. Schechter's Form 4 filing for LABORATORY CORP OF AMERICA HOLDINGS (LH).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Nov 2022, 17:01.
Adam H. Schechter - 01 Nov 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- LH
- Reported as of
- 01 Nov 2022
- Net transaction value
- -$198,746
- SEC form
- 4
- Accepted by SEC
- 03 Nov 2022, 17:01:17 UTC
- Prior SEC filing
- 29 Sep 2022
- Next SEC filing
- 16 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra D. van der Vaart, Attorney-in-Fact for Adam H. Schechter
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Adam H. Schechter filed Form 4 for LABORATORY CORP OF AMERICA HOLDINGS (LH) on 03 Nov 2022.
Change
- Previous filing in this sequence was filed on 29 Sep 2022.
- Current net transaction value: -$198,746.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LH
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,007
- Change %
- +12%
- Price
- Shares after
- 18,481
- Date
- 01 Nov 2022
- Ownership
- Direct
- Footnotes
- F1
LH
transaction
Common Stock
Tax liability
- Transaction value
- $198,746
- Shares
- -893
- Change %
- -4.8%
- Price
- $222.56
- Shares after
- 17,588
- Date
- 01 Nov 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LH
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -2,007
- Change %
- -11%
- Price
- $0.000000
- Shares after
- 17,024
- Date
- 01 Nov 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,007
- Exercise price
- Footnotes
- F1, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
Footnote F2
Stock withholding to satisfy tax withholding obligations.
Footnote F3
The Restricted Stock Units vested in three equal annual installments beginning on November 1, 2020 and are now fully vested.
Footnote F4
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.